Health & Wellbeing

Bravecto for Dogs: Complete Safety, Dosage & Side Effect Guide

Complete guide to Bravecto for dogs — dosage by weight, side effects, safety data, cost, and alternatives. Vet-reviewed flea and tick prevention info.

By Priya Sutaria · Published 10 September 2026
Bravecto for Dogs: Complete Safety, Dosage & Side Effect Guide
⚠️ PRESCRIPTION-ONLY NOTICE: Bravecto (fluralaner) requires a veterinarian prescription and should only be used under veterinary supervision. Never purchase from unauthorized sources or share medication between pets without explicit veterinary direction.

What Is Bravecto Used for in Dogs?

Bravecto is a long-acting parasiticide belonging to the isoxazoline drug class, manufactured by Merck Animal Health. The active ingredient, fluralaner, provides systemic protection against external parasites for up to 12 weeks per dose — a duration that sets it apart from most monthly preventives on the market.

The FDA has approved Bravecto for the following veterinary uses in dogs:

  • Flea treatment and prevention — kills adult fleas (Ctenocephalides felis) and prevents reinfestation for 12 weeks
  • Tick treatment and control — effective against black-legged tick (Ixodes scapularis), American dog tick (Dermacentor variabilis), and brown dog tick (Rhipicephalus sanguineus) for 12 weeks
  • Lone star tick (Amblyomma americanum) — approved for 8 weeks of control
  • Treatment and control of sarcoptic mange (sarcoptic scabies mites) — single dose typically curative
  • Treatment and control of demodectic mange (demodex mites) — single dose, though severe cases may require follow-up per veterinary assessment

Off-label uses your veterinarian may consider include treatment of ear mite infestations (Otodectes cynotis) and certain cases of Cheyletiella (walking dandruff) mite infestations. These uses are supported by emerging clinical evidence but are not currently on the FDA-approved label.

How Does Bravecto Work? Mechanism of Action

Isoxazoline Mechanism Explained

Fluralaner works by binding to and blocking GABA-gated chloride channels and glutamate-gated chloride channels in the nervous system of parasites. This causes uncontrolled neuronal activity, leading to hyperexcitation, paralysis, and death of fleas and ticks.

Because mammalian GABA and glutamate receptors differ structurally from those in arthropods, fluralaner demonstrates selective toxicity — it is lethal to parasites at doses that are safe for dogs. However, this selectivity is not absolute, which is why neurological side effects can occur in susceptible individuals.

Key pharmacokinetic data: After oral administration, fluralaner is absorbed into the bloodstream and distributes throughout body tissues. Fleas and ticks are killed when they bite the treated dog and ingest blood containing the drug. Fleas begin dying within 2 hours of administration, with >98% efficacy achieved within 12 hours. Ticks begin dying within 12 hours, with >99% efficacy by 48 hours.

The extended 12-week duration is achieved through fluralaner's exceptionally long elimination half-life in dogs — approximately 12-15 days. The drug accumulates in fat tissue and is slowly released, maintaining therapeutic blood levels throughout the dosing interval. It is primarily excreted through feces (via biliary elimination), with minimal renal excretion.

Bravecto Dosage by Dog Weight and Condition

Bravecto chewable tablets are dosed by weight class, with each tablet delivering a specific fluralaner amount. The target dosage is approximately 25-56 mg/kg (11.4-25.4 mg/lb) per dose, administered once every 12 weeks for flea and tick prevention.

Weight Class Tablet Strength Fluralaner per Tablet Dosing Frequency
4.4 – 9.9 lb (2 – 4.5 kg) Bravecto 112.5 mg 112.5 mg Every 12 weeks
10 – 22 lb (4.5 – 10 kg) Bravecto 250 mg 250 mg Every 12 weeks
22.1 – 44 lb (10 – 20 kg) Bravecto 500 mg 500 mg Every 12 weeks
44.1 – 88 lb (20 – 40 kg) Bravecto 1000 mg 1000 mg Every 12 weeks
88.1 – 123.8 lb (40 – 56 kg) Bravecto 1400 mg 1400 mg Every 12 weeks

For mange treatment: The same single-dose weight-based tablet is used. Sarcoptic mange typically resolves with one dose. Demodectic mange may require a second dose at 8-12 weeks depending on severity and veterinary assessment. Your vet may perform follow-up skin scrapings to confirm mite elimination.

Administration Instructions

Bravecto chewable tablets should be administered with food or within 20 minutes of a meal. This is not optional — food significantly increases fluralaner absorption. Studies show bioavailability drops by approximately 40-50% when given on an empty stomach, which could result in sub-therapeutic levels and reduced parasite kill rates.

The tablets are flavored (pork liver) and most dogs accept them readily. If your dog spits out or vomits the tablet within 2 hours of administration, contact your veterinarian — a replacement dose may be needed. If vomiting occurs after 2 hours, sufficient absorption has typically occurred.

Side Effects of Bravecto: What to Watch For

In pre-approval field studies and post-market surveillance reported to the FDA, Bravecto demonstrated an overall safety profile consistent with other isoxazoline-class drugs. Most side effects are mild and self-limiting, but serious neurological events have been reported.

Side Effect Reported Frequency Typical Onset Severity
Vomiting 1.9% Within 24 hours Mild, self-limiting
Diarrhea 1.6% Within 24-48 hours Mild, self-limiting
Decreased appetite 1.3% Within 24 hours Mild, resolves within 1-2 days
Lethargy / drowsiness 1.1% Within 24 hours Mild, resolves within 1-2 days
Flatulence 0.6% Within 24 hours Mild
Seizures / tremors Rare (<0.1%) Hours to days Serious — emergency
Muscle tremors / ataxia Rare (<0.1%) Hours to days Serious — emergency

🚨 When to Seek Immediate Veterinary Care

Contact your veterinarian or an emergency clinic immediately if your dog exhibits any of the following after receiving Bravecto:

  • Seizures or convulsions of any duration
  • Uncontrolled muscle tremors or shaking lasting more than 30 minutes
  • Ataxia (stumbling, inability to walk normally, loss of coordination)
  • Persistent vomiting (more than 3 episodes in 24 hours)
  • Complete refusal to eat for more than 48 hours
  • Sudden behavioral changes — disorientation, aggression, or extreme lethargy

ASPCA Animal Poison Control: (888) 426-4435 (24/7, consultation fee applies) if overdose is suspected.

A note on neurological risk: In September 2018, the FDA issued an advisory about the isoxazoline drug class (including Bravecto, NexGard, Simparica, and Credelio), noting that these drugs can cause neurologic adverse events including muscle tremors, ataxia, and seizures. Dogs with a pre-existing seizure disorder are at higher risk. The FDA has not withdrawn approval but requires updated labeling. Discuss your dog's individual risk factors with your veterinarian before starting any isoxazoline.

Contraindications: Dogs Who Should NOT Receive Bravecto

Bravecto is not appropriate for every dog. The following contraindications should be discussed with your veterinarian:

  • Puppies under 6 months of age — safety has not been established in this age group. The FDA-approved label specifies use in dogs 6 months and older.
  • Dogs under 4.4 lb (2 kg) — the lowest available tablet strength delivers a dose too high for very small dogs.
  • Dogs with a known seizure disorder — including idiopathic epilepsy. While not an absolute contraindication, the risk-benefit analysis must be carefully evaluated by your vet. Many neurologists recommend avoiding isoxazolines in dogs with active or poorly controlled epilepsy.
  • Dogs with a history of adverse reaction to fluralaner or other isoxazolines — cross-reactivity between drugs in this class is possible.
  • Pregnant, breeding, or lactating dogs — Bravecto has been evaluated and shown to be safe in breeding, pregnant, and lactating dogs at labeled doses, but your vet should confirm this is appropriate for your individual dog.

Drug Interactions to Know About

Fluralaner is metabolized primarily by hepatic (liver) enzymes, specifically the cytochrome P450 system. While clinically significant drug interactions are relatively uncommon, several combinations warrant caution:

Concurrent Medication Interaction Type Clinical Significance
Phenobarbital (seizure medication) Hepatic enzyme induction — may accelerate fluralaner metabolism Moderate: could reduce Bravecto efficacy and duration. Vet may recommend shorter dosing intervals.
Potassium bromide Additive neurological depression possible Low-moderate: monitor for increased sedation or ataxia.
Other isoxazolines (NexGard, Simparica, Credelio) Duplicate therapy — additive toxicity risk High: never combine two isoxazoline products simultaneously.
NSAIDs (carprofen, meloxicam, deracoxib) No direct pharmacokinetic interaction documented Low: commonly co-administered safely, but report any GI upset.
Systemic corticosteroids (prednisone) No direct interaction documented Low: generally safe to co-administer.
Ivermectin / milbemycin (heartworm preventives) No direct interaction at labeled doses Low: commonly used together in practice. Heartworm preventives from different classes are routinely co-prescribed.

Always provide your veterinarian with a complete list of every medication, supplement, and over-the-counter product your dog receives — including flea/tick collars, topical preventives, and herbal remedies — before starting Bravecto.

Monitoring, Missed Doses, and Overdose Protocol

Routine Monitoring Requirements

For healthy dogs on Bravecto solely for flea and tick prevention, no specific blood work or laboratory monitoring is required beyond routine annual wellness exams. However, your veterinarian may recommend:

  • Baseline wellness panel (CBC, chemistry) if this is your dog's first prescription parasiticide or if your dog is over 7 years old
  • Follow-up skin scrapings at 4 and 8 weeks post-treatment if Bravecto was prescribed for mange — to confirm mite elimination
  • Neurological monitoring — observe your dog closely for 24-72 hours after each dose, particularly the first dose, for any signs of tremors, ataxia, or behavioral changes

What to Do If You Miss a Dose

Because Bravecto is administered every 12 weeks, missing a dose creates a significant gap in parasite protection. If you realize a dose was missed:

  1. Administer the missed dose immediately with food as soon as you remember.
  2. Reset the 12-week clock from the date the missed dose was actually given — not from the original due date.
  3. Do NOT double-dose to "catch up." Give only one tablet at the appropriate weight-class strength.
  4. Inspect your dog thoroughly for fleas and ticks, as the protection gap may have allowed infestation. Your vet may recommend a fast-acting oral adulticide (such as nitenpyram/Capstar) for immediate flea kill while waiting for Bravecto to reach full efficacy.
  5. Set a calendar reminder or use the Bravecto reminder tools to prevent future gaps.

Overdose: Signs and Response

In safety studies, dogs administered fluralaner at 3x and 5x the recommended dose showed no serious adverse effects, suggesting a reasonable safety margin. However, individual sensitivity varies, and any suspected overdose should be treated seriously.

Overdose symptoms may include: vomiting, diarrhea, excessive salivation, tremors, seizures, ataxia, or extreme lethargy.

Immediate steps:

  1. Remove any remaining tablet pieces from your dog's reach.
  2. Note the time of ingestion and the tablet strength consumed.
  3. Contact your veterinarian or an emergency veterinary clinic immediately.
  4. Call ASPCA Animal Poison Control at (888) 426-4435 (24/7, consultation fee applies) for guidance.
  5. Do not induce vomiting unless specifically instructed by a veterinary professional.

Cost, Availability, and Generic Alternatives

Bravecto is available exclusively through licensed veterinarians and authorized online pharmacies that require prescription verification. Pricing varies by weight class, region, and purchasing channel.

Weight Class Per Dose (Vet Office) Per Dose (Authorized Online) Annual Cost (4 doses)
4.4 – 9.9 lb $45 – $55 $38 – $48 $152 – $220
10 – 22 lb $48 – $60 $40 – $52 $160 – $240
22.1 – 44 lb $52 – $65 $44 – $56 $176 – $260
44.1 – 88 lb $56 – $72 $48 – $62 $192 – $288
88.1 – 123.8 lb $62 – $80 $52 – $68 $208 – $320

Generic availability: As of 2026, fluralaner generics are entering the market following patent expirations in several regions. Generic fluralaner chewables may be available at 15-25% lower cost than brand-name Bravecto. Ask your veterinarian whether a generic equivalent is appropriate and available in your area. Ensure any generic carries FDA approval (or equivalent regulatory approval in your country).

Cost comparison context: While Bravecto's per-dose cost appears higher than monthly products, the annual cost accounts for only 4 doses versus 12 doses for monthly preventives. When calculated on a per-month basis, Bravecto averages $13-24/month compared to $15-30/month for many monthly oral preventives — making it competitively priced when compliance is factored in.

Alternatives to Bravecto for Flea and Tick Prevention

If Bravecto isn't the right fit for your dog — whether due to cost, side effect concerns, or seizure history — several alternatives exist across different drug classes and administration routes.

Product Active Ingredient Duration Drug Class Key Difference
NexGard Afoxolaner Monthly Isoxazoline Same drug class as Bravecto; shorter duration allows faster clearance if side effects occur
Simparica Trio Sarolaner + moxidectin + pyrantel Monthly Isoxazoline + macrocyclic lactone + tetrahydropyrimidine Combines flea/tick with heartworm and intestinal parasite prevention
Credelio Lotilaner Monthly Isoxazoline Must be given within 30 minutes of food; some dogs tolerate it better than other isoxazolines
Seresto Collar Imidacloprid + flumethrin Up to 8 months Neonicotinoid + pyrethroid Non-isoxazoline option; topical/collar route avoids systemic exposure; not for dogs who swim frequently
Frontline Plus Fipronil + (S)-methoprene Monthly Phenylpyrazole + insect growth regulator Topical; non-isoxazoline; widely available OTC; increasing flea resistance reported in some regions
K9 Advantix II Imidacloprid + permethrin + pyriproxyfen Monthly Neonicotinoid + pyrethroid + IGR Topical; repels mosquitoes; TOXIC TO CATS — never use in multi-pet homes with cats

Important consideration for dogs with seizure disorders: If your veterinarian has recommended avoiding the isoxazoline class entirely, non-isoxazoline options like the Seresto collar, Frontline Plus, or K9 Advantix II may be preferable. However, these alternatives may offer less comprehensive tick-borne disease prevention, so discuss your regional tick risk with your vet.

Frequently Asked Questions

How long does my dog need to be on Bravecto?

For flea and tick prevention, Bravecto is intended for year-round use in most regions of the United States. Fleas can survive indoors during winter, and ticks in many areas remain active whenever temperatures exceed 40°F (4°C). Your veterinarian may recommend seasonal use only if you live in a region with consistently freezing winters and your dog has minimal outdoor exposure during cold months. For mange treatment, a single dose (or two doses for severe demodectic mange) is typically sufficient, and ongoing use is only needed if you continue flea/tick prevention.

Can I give Bravecto to my dog if they are on heartworm medication?

Yes, Bravecto is commonly co-administered with heartworm preventives such as Heartgard Plus (ivermectin/pyrantel), Interceptor Plus (milbemycin/praziquantel), or Revolution (selamectin). These products target different parasite classes and do not have clinically significant interactions at labeled doses. However, always inform your veterinarian of all medications your dog receives so they can confirm safe combination use.

Is Bravecto safe for MDR1 gene mutation dogs?

Dogs with the MDR1 (ABCB1) gene mutation — common in Australian Shepherds, Collies, Shetland Sheepdogs, and related herding breeds — have altered drug transport across the blood-brain barrier, making them more sensitive to certain medications. Fluralaner is not a known substrate of the P-glycoprotein transporter affected by the MDR1 mutation, and the Washington State University Veterinary Genetics Laboratory does not list fluralaner as a drug of concern for MDR1-mutant dogs. However, always inform your veterinarian of your dog's MDR1 status before starting any new medication.

My dog threw up after taking Bravecto. Do I need to re-dose?

If vomiting occurs within 2 hours of administration, contact your veterinarian — a replacement dose is typically recommended because absorption may be incomplete. If vomiting occurs more than 2 hours after dosing, sufficient fluralaner has been absorbed into the bloodstream, and re-dosing is generally not necessary. Mild vomiting is one of the more commonly reported side effects (1.9% frequency) and usually resolves without intervention.

Does Bravecto protect against mosquitoes or heartworm?

No. Bravecto does not repel or kill mosquitoes and provides no heartworm prevention. You will need a separate heartworm preventive medication. Some combination products (like Simparica Trio) bundle flea/tick, heartworm, and intestinal parasite protection into one monthly chewable — ask your veterinarian if a combination product makes sense for your dog's needs and your budget.

Can I use Bravecto topical solution instead of the chewable tablet?

Bravecto is also available as a topical solution (Bravecto Topical Solution for Dogs), applied to the skin between the shoulder blades. The topical formulation contains the same active ingredient (fluralaner) at the same dosing interval (12 weeks) and provides equivalent flea and tick protection. The topical version may be preferable for dogs that are difficult to pill or that have a history of vomiting after oral medications. Discuss the best formulation for your dog with your veterinarian.

Key Takeaways

  • Bravecto provides 12-week flea and tick protection with a single dose — reducing compliance burden compared to monthly products.
  • Always administer with food for proper absorption.
  • Neurological side effects are rare but serious — monitor your dog closely after each dose, especially the first.
  • Dogs with seizure disorders should use isoxazolines only after careful veterinary risk assessment.
  • Consult your veterinarian before starting, switching, or discontinuing any parasiticide medication.

Sources: FDA Advisory on Isoxazoline Class; Merck Veterinary Manual — Isoxazolines; AKC Flea and Tick Prevention Guide.

Written by

Priya Sutaria

All our authors care for dogs every day — read more of their work on the authors page.